Pelthos Therapeutics Inc

PTHSAMEX · Biological Products, (No Diagnostic Substances)

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

3.72M

on 2026-06-30, from 577K on 2024-03-31 10-Q ↗

Earlier counts are adjusted for the 1-for-10 reverse split; each bar's tip shows the count as filed.

a raise that quarter, at its price

Newest

$200.0M

S-3 of 2026-02-02. 1 prospectus supplement filed under it since. S-3 ↗

7 of its filings are not read yet.

Warrants

The 10-Q filed 2026-08-13 is not read yet.

Cash

2.3 quarters

$24.2M on 2026-06-30 ÷ $10.6M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2025-11-06	Private placement	not read	not read	$18.0M	8-K ↗

Also on file: up to $50.0M term loan agreed 2026-01-13 8-K ↗